Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Viennese biotech company concludes licensing agreement with Columbia University

Photo: APA (Hochmuth) © Photo: APA (Hochmuth)

The basis of the agreement between Apeiron and Columbia Technology Ventures is a patented technology enabling the inhibition of the immune checkpoint Cbl-b in T-lymphocytes in cancer treatment. Thanks to this agreement, Apeiron is given worldwide exclusive rights to use this technology to develop and commercialize active cellular immunotherapies and thus further expand its own patent portfolio for the Cbl-b blockade.

The project is based on the research work carried out by Josef Penninger, who is the Head of the Institute for Molecular Biotechnology (IMBA) in Vienna. A patent was granted. However, at about the same time, a research group at Columbia University also received a patent in this area. In order to avoid future conflicts, Apeiron has striven to obtain the relevant licensing, according to Apeiron Managing Director Hans Loibner.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Expand to Austria

    26.06.2019, Brescia, Italy

  • Research Dialogue with Summery Jazz Sounds

    02.07.2019, Stuttgart, Germany

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Ottobock invests EUR 2 million in Vienna

The underlying basis of success of the globally recognised development work of the German life sciences company Ottobock being carried out in Vienna is the extremely pronounced medical research landscape offering fertile ground for interdisciplinary R&D projects.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts